Showing 4 of 4 recruiting trials for “Malignant peripheral nerve sheath tumor”
A Window of Opportunity Trial of Mirdametinib Plus Vorinostat for NF1 Associated, H3K27 Trimethylation Deficient Malignant Peripheral Nerve Sheath Tumor [MPNST]
A Study of ASTX727 in People With Malignant Peripheral Nerve Sheath Tumors (MPNST)
👨⚕️ Ping Chi, MD, PhD, Memorial Sloan Kettering Cancer Center📍 7 sites📅 Started Apr 2021View details ↗
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors
👨⚕️ Angela Hirbe, M.D., Ph.D., Washington University School of Medicine📍 13 sites📅 Started Apr 2017View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →